Richard W. Pascoe's most recent trade in Seelos Therapeutics Inc was a trade of 1,666 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 4, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Seelos Therapeutics Inc | Pascoe Richard W. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 1,666 | 1,666 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Richard W. Pascoe | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 09 Mar 2023 | 10,000 | 29,973 (0%) | 0% | 4.2 | 41,978 | Common Stock |
| Zevra Therapeutics Inc | Richard W. Pascoe | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.44 per share. | 13 Jan 2023 | 9,500 | 19,973 (0%) | 0% | 5.4 | 51,679 | Common Stock |
| Zevra Therapeutics Inc | Richard W. Pascoe | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 700,000 | 700,000 | - | - | Stock Option (right to buy) | |
| Seelos Therapeutics Inc | Richard W. Pascoe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Richard W. Pascoe | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 4.92 per share. | 18 May 2022 | 1,767 | 6,252 (0%) | 0% | 4.9 | 8,694 | Common Stock |
| Zevra Therapeutics Inc | Richard W. Pascoe | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 4.93 per share. | 18 May 2022 | 1,700 | 7,952 (0%) | 0% | 4.9 | 8,381 | Common Stock |
| Zevra Therapeutics Inc | Richard W. Pascoe | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 4.91 per share. | 18 May 2022 | 400 | 4,085 (0%) | 0% | 4.9 | 1,964 | Common Stock |
| Zevra Therapeutics Inc | Richard W. Pascoe | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 4.91 per share. | 18 May 2022 | 400 | 4,485 (0%) | 0% | 4.9 | 1,964 | Common Stock |
| Zevra Therapeutics Inc | Richard W. Pascoe | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 4.94 per share. | 18 May 2022 | 333 | 8,285 (0%) | 0% | 4.9 | 1,645 | Common Stock |
| Zevra Therapeutics Inc | Richard W. Pascoe | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 4.90 per share. | 18 May 2022 | 300 | 3,585 (0%) | 0% | 4.9 | 1,470 | Common Stock |
| Zevra Therapeutics Inc | Richard W. Pascoe | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 4.90 per share. | 18 May 2022 | 100 | 3,685 (0%) | 0% | 4.9 | 490 | Common Stock |
| Zevra Therapeutics Inc | Richard W. Pascoe | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 127,286 | 127,286 | - | - | Stock Option (right to buy) | |
| Seelos Therapeutics Inc | Richard W. Pascoe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Richard W. Pascoe | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 7.88 per share. | 30 Nov 2021 | 1,500 | 3,285 (0%) | 0% | 7.9 | 11,822 | Common Stock |
| Zevra Therapeutics Inc | Richard W. Pascoe | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2021 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Richard W. Pascoe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Histogen Inc | Richard W. Pascoe | Director, President, CEO & Director | Purchase of securities on an exchange or from another person at price $ 1.14 per share. | 30 Mar 2021 | 20,000 | 30,000 | - | 1.1 | 22,800 | Common Stock |
| Histogen Inc | Richard W. Pascoe | Director, President, CEO & Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2021 | 346,000 | 346,000 | - | - | Stock Option (right to buy) | |
| Seelos Therapeutics Inc | Richard W. Pascoe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Richard W. Pascoe | Director | Purchase of securities on an exchange or from another person at price $ 0.63 per share. | 18 Aug 2020 | 7,200 | 25,773 (0%) | 0% | 0.6 | 4,565 | Common Stock |
| Zevra Therapeutics Inc | Richard W. Pascoe | Director | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 18 Aug 2020 | 1,800 | 28,573 (0%) | 0% | 0.6 | 1,152 | Common Stock |
| Zevra Therapeutics Inc | Richard W. Pascoe | Director | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 18 Aug 2020 | 1,000 | 26,773 (0%) | 0% | 0.6 | 635 | Common Stock |